ConductScience.org, home

Paper925886

Bioavailability assessment: methods to estimate total area (AUC O to infinity) and total amount excreted (A infinity e) and importance of blood and urine sampling scheme with application to digoxin.

Wagner JG and 1 other. J Pharmacokinet Biopharm, 1977. Cited by 51 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Bioavailability assessment: methods to estimate total area (AUC O to infinity) and total amount excreted (A infinity e) and importance of blood and urine sampling scheme with application to digoxin. Papers, record 925886. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/925886

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Bioavailability assessment: methods to estimate total area (AUC O to infinity) and total amount excreted (A infinity e) and importance of blood and urine sampling scheme with application to digoxin.
PubMed
Journal
J Pharmacokinet Biopharm
PubMed
Year
1977
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
51
iCite
Relative citation ratio, by iCite
3.37
iCite
Revised in PubMed
2026-10-11
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wagner JGJ G
2Ayres JWJ W

Source PubMed

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Biological AvailabilityMajor topic
BiopharmaceuticsMajor topic
DigoxinMajor topic
Humans
Mathematics

Source PubMed

References27

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14,122,564Correlation of digoxin-tablet dissolution-rate with biological availability.Lancet1973https://conductscience.org/library/papers/4122564PubMed
21,159,622Pharmacokinetics of digoxin in normal subjects after intravenous bolus and infusion doses.J Pharmacokinet Biopharm1975https://conductscience.org/library/papers/1159622PubMed
34,827,467Intravenous digoxin as a bioavailability standard: slow infusion and rapid injection.Clin Pharmacol Ther1974https://conductscience.org/library/papers/4827467PubMed
44,850,764Bioavailability and dissolution properties of two commercial digoxin tablets.J Pharm Sci1974https://conductscience.org/library/papers/4850764PubMed
51,269,214A completely absorbed oral preparation of digoxin.Clin Pharmacol Ther1976https://conductscience.org/library/papers/1269214PubMed
61,122,665Letter: Intravenous digoxin as a bioavailability standard.Clin Pharmacol Ther1975https://conductscience.org/library/papers/1122665PubMed
74,752,307Pharmacokinetics of digoxin: interpreting bioavailability.Br Med J1973https://conductscience.org/library/papers/4752307PubMed
8797,491Bioavailability of drugs: the digoxin dilemma.Clin Pharmacokinet1976https://conductscience.org/library/papers/797491PubMed
9959,319Assessment of methodology in single-dose studies of digoxin bioavailability.Pharmacology1976https://conductscience.org/library/papers/959319PubMed
104,644,642An overview of the analysis and interpretation of bioavailability studies in man.Pharmacology1972https://conductscience.org/library/papers/4644642PubMed
114,412,196Bioavailability of digoxin tablets and elixir in the fasting and postprandial states.Clin Pharmacol Ther1974https://conductscience.org/library/papers/4412196PubMed
12957,127Biased bioavailability estimates.J Pharm Sci1976https://conductscience.org/library/papers/957127PubMed
13859,101Pharmacokinetic data. Pharmacokinetic parameters estimated from intravenous data by uniform methods and some of their uses.J Pharmacokinet Biopharm1977https://conductscience.org/library/papers/859101PubMed
144,426,150Comparison of one- and six-day urinary digoxin excretion in single-dose bioavailability studies.Clin Pharmacol Ther1974https://conductscience.org/library/papers/4426150PubMed
154,741,375Curve fitting by spline and Akima methods: possibility of interpolation error and its suppression.Phys Med Biol1973https://conductscience.org/library/papers/4741375PubMed
164,758,424Biological availability of digoxin from Lanoxin produced in the United Kingdom.Br Med J1973https://conductscience.org/library/papers/4758424PubMed
174,479,121Equivalent bioavailability from digoxin elixir and rapid-dissolution tablets.JAMA1974https://conductscience.org/library/papers/4479121PubMed
1810,123Effect of sulfasalazine on digoxin bioavailability.Clin Pharmacol Ther1976https://conductscience.org/library/papers/10123PubMed
194,678,961Absorption of orally given digoxin preparations.JAMA1972https://conductscience.org/library/papers/4678961PubMed
204,739,492Equivalence lack in digoxin plasma levels.JAMA1973https://conductscience.org/library/papers/4739492PubMed

See all 27 references

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 51 citations.

PMIDTitleJournalYearIn PapersSource
21,446,834Organophosphorus pesticide degradation product in vitro metabolic stability and time-course uptake and elimination in rats following oral and intravenous dosing.Xenobiotica2011https://conductscience.org/library/papers/21446834PubMed
20,218,011Comparison of the in vitro and in vivo release of digoxin from four different soft gelatin capsule formulations.J Pharmacokinet Biopharm1979https://conductscience.org/library/papers/20218011PubMed
19,430,911Prediction of modified release pharmacokinetics and pharmacodynamics from in vitro, immediate release, and intravenous data.AAPS J2009https://conductscience.org/library/papers/19430911PubMed
7,306,427Absorption and bioavailability of oral erythromycin.Br J Clin Pharmacol1981https://conductscience.org/library/papers/7306427PubMed
7,277,206Evidence of nonlinearity in digoxin pharmacokinetics.J Pharmacokinet Biopharm1981https://conductscience.org/library/papers/7277206PubMed
7,014,827A standard approach to compiling clinical pharmacokinetic data.J Pharmacokinet Biopharm1981https://conductscience.org/library/papers/7014827PubMed
6,668,552Sampling strategies for noncompartmental estimation of mean residence time.J Pharmacokinet Biopharm1983https://conductscience.org/library/papers/6668552PubMed
3,830,717Steroid metabolism in isolated rat hepatocytes.Eur J Drug Metab Pharmacokinet1985https://conductscience.org/library/papers/3830717PubMed
2,614,683Optimal design allocations for estimating area under curves for studies employing destructive sampling.J Pharmacokinet Biopharm1989https://conductscience.org/library/papers/2614683PubMed
671,227Time to reach steady state and prediction of steady-state concentrations for drugs obeying Michaelis-Menten elimination kinetics.J Pharmacokinet Biopharm1978https://conductscience.org/library/papers/671227PubMed
41,924A method to predict infinity values for biexponential processes.J Pharmacokinet Biopharm1979https://conductscience.org/library/papers/41924PubMed
39,764Methods for evaluation of urinary excretion parameters of alclofenac after I.M. administration of its water soluble lysine salt in man.Eur J Drug Metab Pharmacokinet1979https://conductscience.org/library/papers/39764PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/925886

GET https://conductscience.org/api/papers/v1/925886/references?page=2